NanoViricides
NNVC
#10125
Rank
โ‚น2.01 B
Marketcap
โ‚น111.83
Share price
-1.60%
Change (1 day)
-10.90%
Change (1 year)

NanoViricides (NNVC) - Net assets

Net assets on the balance sheet as of September 2025 : โ‚น0.65 Billion

According to NanoViricides's latest financial reports the company has โ‚น0.65 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

NanoViricides - Net assets on balance sheet (from 2006 to 2025)

Net assets by year

Year Net assets Change
2024-06-30$โ‚น0.95 B-21.65%
2023-06-30$โ‚น1.21 B-33.07%
2022-06-30$โ‚น1.82 B-18.07%
2021-06-30$โ‚น2.22 B34.97%
2020-06-30$โ‚น1.64 B125.53%
2019-06-30$โ‚น0.73 B-39.56%
2018-06-30$โ‚น1.20 B-7.93%
2017-06-30$โ‚น1.31 B-15.59%
2016-06-30$โ‚น1.55 B-23.03%
2015-06-30$โ‚น2.02 B44.23%
2014-06-30$โ‚น1.40 B193.94%
2013-06-30$โ‚น0.47 B-37.99%
2012-06-30$โ‚น0.76 B69.52%
2011-06-30$โ‚น0.45 B49.92%
2010-06-30$โ‚น0.30 B154.36%
2009-06-30$โ‚น0.11 B524.5%
2008-06-30$โ‚น19.04 M-6.09%
2007-06-30$โ‚น20.27 M-64.66%
2006-06-30$โ‚น57.38 M-2098.7%
2005-06-30$-โ‚น2.88 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
BioCryst Pharmaceuticals
BCRX
-โ‚น35.27 Billion-5,506.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-โ‚น14.25 Billion-2,283.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น1.950 T 298,951.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น1.691 T 259,144.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น4.719 T 723,373.77%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น1.925 T 295,048.64%๐Ÿ‡ฌ๐Ÿ‡ง UK